In Europe and the US, aortic stenosis is the most frequent cause of valve intervention, both surgical and percutaneous, and, as we all know, TAVR has made great progress in this regard. However, this technique has an Achilles heel when it comes to self-expandable valves: definite pacemaker implantation rate is 3 to 4 times higher...
Currently, edge-to-edge therapy with MitraClip has demonstrated efficacy and safety for the treatment of patients with degenerative or functional mitral regurgitation who are at high risk for surgery. However, device-related complications are still present—though their frequency is subsiding due to greater experience, 3D doppler echocardiography development, and technological advancements: loss of leaflet insertion (LLI), single...
By Women as One: https://womenasone.org/ Everyone is entitled to human rights. However, in 2021 women are still experiencing discrimination in multiple forms. UNESCO and the World Economic Forum’s Global Gender Gap Report 2021 both found that the time needed to close the gender gap worldwide has increased from 99.5 years to 135.6 years. In this infographic, we highlight the gender gaps...
Infective Endocarditis (IE) rate after TAVR ranges from 0.7% to 3.4%, depending on the different analyses, and is comparable to that after SAVR. Close to 50% of patients treated with surgery received a prosthetic valve; in TAVR, the figure is lower, possibly due to the characteristics of patients (even though it remains unclear). Researchers looked...
Positron emission tomography (PET) with F sodium fluoride (F-NaF) allows for the assessment of microcalcification activity (MA) in a wide variety of cardiovascular conditions, including atherosclerosis. In coronary artery disease, this tracer correlates with progressive disease and allows for the prediction of atherosclerosis progression. Unlike PETs, computed tomography (CT) allows for the evaluation of an...
It is with deep sorrow that the Board of Directors and all SOLACI office staff announce the passing of Dr. Gaspar Caponi. Not only did Dr. Caponi provide healthcare assistance as an interventional cardiologist at the Favaloro Foundation University Hospital, but—because of his academic and scientific vocation—he was also a close collaborator to SOLACI. His...
Learn about the Latin American Registry of the Percutaneous Intervention of Coronary Bifurcations January 2022 report. The registry has already enrolled over 700 patients, which makes us most proud. More than 23 centers from Argentina, Mexico, Peru, Colombia, Ecuador, Bolivia, and Guatemala have joined the registry. For those who still haven’t heard of it, LATAM...
After a year of hard work, LATAM Bif-SOLACI has included over 700 patients! From SOLACI Research and the Registry Board of Directors we are glad to lead this important research initiative and we hope to keep growing in the coming months and be able to contribute with reliable data that will allow us to perfect...
The answer is incontrovertible: it is undeniably effective. For all ages, the confirmed COVID19 and severe case rates were significantly lower for patients who had received the BNT162b2 (Pfizer/BioNTech) booster dose vs individuals with only two shots. After the initial promising results of the mRNA COVID-19 vaccine booster dose given to +60 men and women, Israel...
The PRAGUE-17 has shown that left atrial appendage closure is not inferior to direct anticoagulants at long term to prevent major cardiovascular, neurological, or bleeding events. Moreover, procedures not related to prosthesis implantation saw significant reduction. The PRAGUE-17 was a randomized non-inferiority study comparing left atrial appendage closure (Watchman or Amulet) with direct anticoagulants (95%...